Johnathan Chappell, MD
Dermatology · Acworth, GANPI 1831385897
Payments from drug & device makers
Across 56 payments — averaging $48.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Journey Medical Corporation$2K
- AbbVie$328
- Galderma Laboratories, L.p.$226
- E.r. Squibb & Sons, L.L.C.$152
- Johnson & Johnson$123
- Dermavant Sciences, Inc.$101
- plus $299 from 11 others
What the payments were for
- Consulting fees$1,50055%
- Food & beverage$1,22845%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Journey Medical Corporation | 1 | $1,500 |
| AbbVie | 14 | $328 |
| Galderma Laboratories, L.p. | 13 | $226 |
| E.r. Squibb & Sons, L.L.C. | 2 | $152 |
| Johnson & Johnson | 6 | $123 |
| Dermavant Sciences, Inc. | 5 | $101 |
| Mayne Pharma Commercial LLC | 2 | $46 |
| Lilly USA, LLC | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 2 | $36 |
| Pfizer | 2 | $34 |
| Sun Pharmaceutical Industries Inc. | 1 | $24 |
| Incyte Corporation | 1 | $24 |
| Amgen | 1 | $23 |
| UCB, Inc. | 1 | $21 |
| Organon | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Sotyktu$122
How this compares
$2,728 in reported general payments places this provider in the 35th percentile of 345 dermatology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 17 | $63,629 |
| Fluorouracil | 73 | $5,595 |
| Triamcinolone Acetonide | 284 | $3,239 |
| Ketoconazole | 200 | $2,384 |
| Clobetasol Propionate | 54 | $1,776 |
| Metronidazole | 28 | $1,755 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 27 | $1,396 |
| Doxycycline Hyclate | 56 | $1,331 |
| Betamethasone Dipropionate | 39 | $1,086 |
| Hydrocortisone | 120 | $825 |
| Nystatin | 50 | $772 |
| Hydroxyzine Hcl | 72 | $669 |
| Tretinoin | 17 | $527 |
| ErythromycinErythromycin Base In Ethanol | 13 | $420 |
| ValacyclovirValacyclovir Hcl | 12 | $222 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Acworth
- David CohenMacon$5.5M
- Jamie WeismanAtlanta$4.9M
- Tiffani HamiltonAlpharetta$3.3M
- Firas HougeirDouglasville$3.3M
- Jonathan WeissSnellville$2.4M
- Mark KnautzPowder Springs$1.7M
- Gerald SlagelFayetteville$1.2M
- Zakiya RiceAtlanta$1.1M
- Corinne HowingtonSavannah$874K
- Alia BrownSnellville$838K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.